(PRWEB) November 06, 2017
Global law firm Greenberg Traurig, LLP Of Counsel Karen C. Corallo will be presenting at the 2017 Minneapolis Medical Design & Manufacturing (MD&M) Conference, Nov. 8-9, in Minneapolis, Minnesota. In its 23rd year, MD&M is the biggest medtech event, bringing together more than 5,500 professionals and 600 suppliers in the industry.
Corallo will speak at the session titled, “Intended Use vs. Indications for Use: How to Get your Regulatory Submission Right the First Time.” ‘Intended use’ and ‘indications for use’ are two terms that are often mistakenly treated as interchangeable. Her presentation will explain why the difference between the two matters from a regulatory perspective. Topics covered will include: what is the difference in terminology, why does product classification matter, and understanding the impact on design controls and quality measures.
Corallo represents pharmaceutical and medical device industry clients on administrative, regulatory, and enforcement matters.
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP (GTLaw) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East and is celebrating its 50th anniversary. One firm worldwide, GTLaw has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and among the Top 20 on the 2016 Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.